5-methyl-4-[[1-[(3R)-3-methyloxolan-3-yl]-2H-pyrazin-6-yl]oxymethyl]-3-(6-methyl-3-pyridinyl)-1,2-oxazole
C20H24N4O3 — CID 151119586
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-methyl-4-[[1-[(3R)-3-methyloxolan-3-yl]-2H-pyrazin-6-yl]oxymethyl]-3-(6-methyl-3-pyridinyl)-1,2-oxazole
5-methyl-4-[[1-[(3R)-3-methyloxolan-3-yl]-2H-pyrazin-6-yl]oxymethyl]-3-(6-methyl-3-pyridinyl)-1,2-oxazole (PubChem CID 151119586) has the molecular formula C20H24N4O3 and a molecular weight of 368.44 g/mol. Its IUPAC name is 5-methyl-4-[[1-[(3R)-3-methyloxolan-3-yl]-2H-pyrazin-6-yl]oxymethyl]-3-(6-methyl-3-pyridinyl)-1,2-oxazole.
Molecular Properties
| Compound Name | 5-methyl-4-[[1-[(3R)-3-methyloxolan-3-yl]-2H-pyrazin-6-yl]oxymethyl]-3-(6-methyl-3-pyridinyl)-1,2-oxazole |
|---|---|
| PubChem CID | 151119586 |
| Molecular Formula | C20H24N4O3 |
| Molecular Weight | 368.44 g/mol |
| Exact Mass | 368.18 |
| IUPAC Name | 5-methyl-4-[[1-[(3R)-3-methyloxolan-3-yl]-2H-pyrazin-6-yl]oxymethyl]-3-(6-methyl-3-pyridinyl)-1,2-oxazole |
| SMILES | Cc1ccc(-c2noc(C)c2COC2=CN=CCN2[C@]2(C)CCOC2)cn1 |
| InChI | InChI=1S/C20H24N4O3/c1-14-4-5-16(10-22-14)19-17(15(2)27-23-19)12-26-18-11-21-7-8-24(18)20(3)6-9-25-13-20/h4-5,7,10-11H,6,8-9,12-13H2,1-3H3/t20-/m1/s1 |
| InChIKey | MRXACUZABCIWCQ-HXUWFJFHSA-N |
| XLogP | 3.23 |
| TPSA | 72.98 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 368.44 |
| LogP ≤ 5 | 3.23 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 151119586 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.